COMP <GO>

XBI vs VTI // OPTIONS IMPLIED MOVE & PUT/CALL SKEW

SPDR S&P Biotech ETF (NYSE) VS. Vanguard Total Stock Market ETF (NYSE) • 15-METRIC TALLY: XBI 1 — VTI 1

■ METRIC PARITY

LAST: $155.98 (-1.15%) • MKT CAP: $7.40B

options-implied-move

3.20%

LAST: $371.57 (-1.76%) • MKT CAP: $465.00B

options-implied-move

3.20%

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XBI VS. VTI) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	XBI	VTI	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	58.00%	58.00%	0.00	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	19.50%	19.50%	0.00	TIE	/roic <GO>
EV/EBITDA & P/E Valuation	—	—	—	TIE	/valuation <GO>
Free Cash Flow Yield	3.40%	3.40%	0.00	TIE	/fcf-yield <GO>
Operating Margin	24.00%	24.00%	0.00	TIE	/operating-margins <GO>
Net Profit Margin	18.50%	18.50%	0.00	TIE	/net-margins <GO>
Revenue Growth (YoY)	9.20%	9.20%	0.00	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	1.30%	1.30%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	4.80	4.80	0.00	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	7/9	7/9	0.00	TIE	/piotroski-score <GO>
Options Implied Move & Put/Call Skew ACTIVE	3.20%	3.20%	0.00	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	54.1	41.1	+13.00	XBI	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	1.00	1.00	0.00	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	19.8x	19.8x	0.00	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$7.40B	$465.00B	-$457.60B	VTI	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	XBI REV	VTI REV	XBI GROSS %	VTI GROSS %	XBI FCF	VTI FCF
INSPECT INDIVIDUAL XBRL MODELS AT XBI FA <GO> AND VTI FA <GO>.

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

XBI // BETA 1.00

VTI // BETA 1.00